Abstract
Abstract The fibrolamellar variant of hepatocellular carcinoma (FL-HCC) is a primary malignancy of the liver classically identified in the non-cirrhotic liver. By virtue of the non-cirrhotic liver background, patients with FL-HCC are more likely to be selected for surgical resection as primary treatment than in classic HCC. Synchronous and metachranous metastasis of FL-HCC can be treated with either resection, chemotherapy, or both. We present here an adolescent who underwent resection of a large FL-HCC following neo-adjuvant chemotherapy. The patient went on to receive surveillance and resection of five serially identified metastasis. Despite repeated aggressive metastasectomy, we observed survival in this case surpassing the median reported survival for adolescents with FL-HCC. This case supports the hypothesis proposed previously that aggressive surgical resection, including metastasectomy in the thoracic and abdominal cavity, should be offered to patients with this rare tumor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.